Clinical Trial Update: A Study on Immunotherapy Combined With Radiotherapy for Esophagogastric Junction/Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating immunotherapy combined with radiotherapy for gastroesophageal junction and gastric adenocarcinoma; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Gastroesophageal Junction
• Gastric Cancer

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Esophagogastric Junction/Gastric Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING